PT Ramayana Lestari Sentosa Tbk (IDX:RALS)

Ligand Pharmaceuticals Revenue

PT Ramayana Lestari Sentosa Tbk had revenue of 357.43B IDR in the quarter ending June 30, 2025, a decrease of -57.29%. This brings the company's revenue in the last twelve months to 2.60T, down -5.41% year-over-year. In the year 2024, PT Ramayana Lestari Sentosa Tbk had annual revenue of 2.76T with 0.59% growth.

• Revenue (ttm): 2,597.51B
• Revenue Growth: -5.41%
• P/S Ratio: 0.90
• Revenue / Employee: 774.68M
• Employees: 3,395
• Market Cap: 2,336.92B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2,760.51B	16.08B	0.59%
Dec 31, 2023	2,744.43B	-252.19B	-8.42%
Dec 31, 2022	2,996.61B	403.93B	15.58%
Dec 31, 2021	2,592.68B	64.73B	2.56%
Dec 31, 2020	2,527.95B	-3,068.45B	-54.83%